ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0194

Machine Learning Methods to Predict Cardiovascular Risk in Hispanic Patients with Systemic Lupus Erythematosus

Ariana Gonzalez-Melendez1, Jeann Hernandez-Franco2, Dylan Cedres-Rivera3 and Abiel Roche-Lima3, 1University of Puerto Rico - Medical Science Campus, Guaynabo, PR, 2University of Puerto Rico, San Juan, PR, Puerto Rico, 3Center for Collaborative Research in Health Disparities, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, San Juan, PR, Puerto Rico

Meeting: ACR Convergence 2024

Keywords: Disparities, Heart disease, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Healthcare Disparities in Rheumatology Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The most common cause of death among patients with systemic lupus erythematosus (SLE) is cardiovascular disease (CVD). Previous studies have performed cardiovascular risk stratification; however, the association by different ethnicities/races including Hispanics has rarely been evaluated. For this reason, we aim to use machine learning (ML) to identify features associated to CVD risks in patients with SLE among various ethnic groups.

Methods: The data was extracted from NIH All of Us Program. A total of 2,684 individuals with a diagnosis of SLE were selected as our SLE cohort. Demographic parameters, comorbidities, physical measures, other conditions, and observations were included as features (a total of 300 features). Major adverse cardiovascular events (MACE) were the class, defined as a composite outcome of developing acute myocardial infarction, stroke, or cardiovascular death. Individuals (samples) were divided and compared for the following groups: Hispanics (3.8%), Non-Hispanic-White-American (58.2%), Non-Hispanic-African-American (38.0%). The Recursive Feature Elimination algorithm and several ML algorithms (SVC [Support Vector Machine Classifier], GaussianNB [Naive Bayes Classifier], LogisticRegression, LinearDiscriminantAnalysis, RandomForestClassifier, and KNeighborsClassifier) were implemented. We obtained the most precise ML models for each group, along with the corresponding important features associated with MACE. The important features were computed through the permutation_importace function and the “Important Indexes” (IIs) were obtained.

Results: Out of the SLE cohort (n=2,684), 1,381 (51.6%) had a MACE event. Among Hispanics with SLE, pulmonary hypertension (0.0049), and pulmonary embolism (0.0047), and cardiomegaly (0.0069) exhibit stronger associations with CVD. In Afro-American patients, diabetes (0.0645), hyperlipidemia (0.0104), and heart failure (0.0300) are more closely linked to CVD risk. Conversely, among whites, hypertension (0.0076), chronic kidney disease (0.0131), and gastrointestinal disorders (0.0154) are predominant factors associated with CVD risk.

Conclusion: In this multiethnic cohort of patients with SLE, cardiovascular disease risk factors in patients with systemic lupus erythematosus (SLE) exhibit variations across different ethnic groups. Distinct patterns emerge for Hispanics with SLE, with pulmonary hypertension and pulmonary embolism being more prevalent when compared to non-Hispanics, which in turn is associated with more severe SLE disease and increased CVD risk. Overall, the varying profiles of CVD risk factors among different ethnic groups with SLE highlight the need for personalized approaches to CVD prevention and management in this patient population, taking into account ethnic-specific risk factor profiles and disease manifestations.


Disclosures: A. Gonzalez-Melendez: None; J. Hernandez-Franco: None; D. Cedres-Rivera: None; A. Roche-Lima: None.

To cite this abstract in AMA style:

Gonzalez-Melendez A, Hernandez-Franco J, Cedres-Rivera D, Roche-Lima A. Machine Learning Methods to Predict Cardiovascular Risk in Hispanic Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/machine-learning-methods-to-predict-cardiovascular-risk-in-hispanic-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/machine-learning-methods-to-predict-cardiovascular-risk-in-hispanic-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology